Encyclopedia of Pathology

Living Edition
| Editors: J.H.J.M. van Krieken

Invasive Carcinoma NST

  • Ian EllisEmail author
Living reference work entry
DOI: https://doi.org/10.1007/978-3-319-28845-1_4702-1

Synonyms

Definition

Invasive breast carcinoma of no special type is also commonly known as invasive ductal carcinoma not otherwise specified, comprises the largest group of invasive breast cancers. It is a morphologically heterogeneous group which does not exhibit the features or purity of tumors of recognized special types of breast cancer, such as classical invasive lobular (Invasive Lobular Carcinoma) or tubular carcinoma (Invasive Tubular Carcinoma).

Clinical Features

  • Incidence: Invasive carcinoma NST forms a large proportion of mammary carcinomas and its epidemiological characteristics are similar to those of breast cancer as a whole. The WHO currently identifies that breast cancer is the most frequent cancer among women, impacting 2.1 million women each year, and...

This is a preview of subscription content, log in to check access.

References and Further Reading

  1. Allison, K. H. (2012). Molecular pathology of breast cancer: What a pathologist needs to know. American Journal of Clinical Pathology, 138, 770–780.CrossRefGoogle Scholar
  2. Blamey, R. W., Ellis, I. O., Pinder, S. E., Lee, A. H., Macmillan, R. D., Morgan, D. A., Robertson, J. F., Mitchell, M. J., Ball, G. R., Haybittle, J. L., & Elston, C. W. (2007). Survival of invasive breast cancer according to the Nottingham Prognostic Index in cases diagnosed in 1990–1999. European Journal of Cancer, 43, 1548–1555.CrossRefGoogle Scholar
  3. Blamey, R. W., Hornmark-Stenstam, B., Ball, G., Blichert-Toft, M., Cataliotti, L., Fourquet, A., Gee, J., Holli, K., Jakesz, R., Kerin, M., Mansel, R., Nicholson, R., Pienkowski, T., Pinder, S., Sundquist, M., van de Vijver, M., & Ellis, I. (2010). ONCOPOOL – A European database for 16,944 cases of breast cancer. European Journal of Cancer, 46, 56–71.CrossRefGoogle Scholar
  4. Carlson, R. W., Brown, E., Burstein, H. J., Gradishar, W. J., Hudis, C. A., Loprinzi, C., Mamounas, E. P., Perez, E. A., Pritchard, K., Ravdin, P., Recht, A., Somlo, G., Theriault, R. L., Winer, E. P., & Wolff, A. C. (2006). NCCN Task Force report: Adjuvant therapy for breast cancer. Journal of the National Comprehensive Cancer Network, 4(Suppl 1), S1–S26.PubMedGoogle Scholar
  5. Curigliano, G., Burstein, H. J., Winer, E. P., Gnant, M., Dubsky, P., Loibl, S., Colleoni, M., Regan, M. M., Piccart-Gebhart, M., Senn, H.-J., Thürlimann, B., André, F., Baselga, J., Bergh, J., Bonnefoi, H., Brucker, S. Y., Cardoso, F., Carey, L., Ciruelos, E., Cuzick, J., Denkert, C., Di Leo, A., Ejlertsen, B., Francis, B., Galimberti, V., Garber, J., Gulluoglu, B., Goodwin, P., Harbeck, N., Hayes, D. F., Huang, C. S., Huober, J., Khaled, H., Jassem, J., Jiang, Z., Karlsson, P., Morrow, M., Orecchia, R., Osborne, K. C., Pagani, O., Partridge, A. H., Pritchard, K., Ro, J., Rutgers, E. J. T., Sedlmayer, F., Semiglazov, V., Shao, Z., Smith, I., Toi, M., Tutt, A., Viale, G., Watanabe, T., Whelan, T. J., & Xu, B. (2017). De-escalating and escalating treatments for early-stage breast cancer: The St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017. Annals of Oncology, 28, 1700–1712.CrossRefGoogle Scholar
  6. Early Breast Cancer Trialists’ Collaborative Group (EBCTCG). (2018). Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: Meta-analysis of individual patient data from ten randomised trials. Lancet Oncology, 19, 27–39.CrossRefGoogle Scholar
  7. Ellis, I. O., Al-Sam, S., Anderson, N., Carder, P., Deb, R., Girling, A., Hales, S., Hanby, A., Ibrahim, M., Lee, A. S. H., Liebmann, R., Mallon, E., Pinder, S. E., Provenzano, E., Quinn, C., Rakha, E., Rowlands, D., Stephenson, T., & Wells, C. A. (2016). Pathology reporting of breast disease in surgical excision specimens incorporating the dataset for histological reporting of breast cancer. The Royal College of Pathologists, London. file:https://www.rcpath.org/profession/guidelines/cancer-datasets-and-tissue-pathways.html#
  8. Elston, C. W., & Ellis, I. O. (1991). Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: Experience from a large study with long-term follow-up. Histopathology, 19, 403–410.CrossRefGoogle Scholar
  9. Lakhani, S. R., Ellis, I. O., Schnitt, S. J., Tan, P. H., & van de Vijver, M. J. (2012). WHO classification of tumours of the breast (4th ed.). Lyon: IARC Press.Google Scholar
  10. Lee, A. H. (2007). The histological diagnosis of metastases to the breast from extramammary malignancies. Journal of Clinical Pathology, 60, 1333–1341.CrossRefGoogle Scholar
  11. Perry, N., Broeders, M., de Wolf, C., Törnberg, S., Holland, R., & von Karsa, L. (2006). European guidelines for quality assurance in breast cancer screening and diagnosis (4th ed.). Luxembourg: Office for Official Publications of the European Communities.Google Scholar
  12. Rakha, E. A., & Green, A. R. (2017). Molecular classification of breast cancer: What the pathologist needs to know. Pathology, 49, 111–119.CrossRefGoogle Scholar
  13. Rakha, E. A., Reis-Filho, J. S., Baehner, F., Dabbs, D. J., Decker, T., Eusebi, V., Fox, S. B., Ichihara, S., Jacquemier, J., Lakhani, S. R., Palacios, J., Richardson, A. L., Schnitt, S. J., Schmitt, F. C., Tan, P. H., Tse, G. M., Badve, S., & Ellis, I. O. (2010). Breast cancer prognostic classification in the molecular era: The role of histological grade. Breast Cancer Research, 12, 207.CrossRefGoogle Scholar
  14. Salgado, R., Denkert, C., Demaria, S., Sirtaine, N., Klauschen, F., Pruneri, G., Wienert, S., Van den Eynden, G., Baehner, F. L., Penault-Llorca, F., Perez, E. A., Thompson, E. A., Symmans, W. F., Richardson, A. L., Brock, J., Criscitiello, C., Bailey, H., Ignatiadis, M., Floris, G., Sparano, J., Kos, Z., Nielsen, T., Rimm, D. L., Allison, K. H., Reis-Filho, J. S., Loibl, S., Sotiriou, C., Viale, G., Badve, S., Adams, S., Willard-Gallo, K., Loi, S., & International TILs Working Group 2014. (2015). The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: Recommendations by an International TILs Working Group 2014. Annals of Oncology, 26, 259–271.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.The University of Nottingham, Department of Histopathology, City Hospital Campus, Nottingham University Hospitals, Hucknall Rd, Nottingham NG5 1PBNottinghamUK